Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
We have now added a new section called the "Assay History List" to the "At A Gla...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...